DK1298132T3 - Hydropyridinderivatsyreadditionssalte - Google Patents

Hydropyridinderivatsyreadditionssalte

Info

Publication number
DK1298132T3
DK1298132T3 DK01945799T DK01945799T DK1298132T3 DK 1298132 T3 DK1298132 T3 DK 1298132T3 DK 01945799 T DK01945799 T DK 01945799T DK 01945799 T DK01945799 T DK 01945799T DK 1298132 T3 DK1298132 T3 DK 1298132T3
Authority
DK
Denmark
Prior art keywords
hydropyridinderivatsyreadditionssalte
Prior art date
Application number
DK01945799T
Other languages
English (en)
Inventor
Fumitoshi Asai
Taketoshi Ogawa
Hideo Naganuma
Naotoshi Yamamura
Teruhiko Inoue
Kazuyoshi Nakamura
Original Assignee
Sankyo Co
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to JP2000205396 priority Critical
Priority to JP2000266780 priority
Application filed by Sankyo Co, Ube Industries filed Critical Sankyo Co
Priority to PCT/JP2001/005764 priority patent/WO2002004461A1/ja
Application granted granted Critical
Publication of DK1298132T3 publication Critical patent/DK1298132T3/da
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26595526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1298132(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK01945799T 2000-07-06 2001-07-03 Hydropyridinderivatsyreadditionssalte DK1298132T3 (da)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2000205396 2000-07-06
JP2000266780 2000-09-04
PCT/JP2001/005764 WO2002004461A1 (fr) 2000-07-06 2001-07-03 Sels d'addition acides de dérivés hydropyridine

Publications (1)

Publication Number Publication Date
DK1298132T3 true DK1298132T3 (da) 2007-03-12

Family

ID=26595526

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01945799T DK1298132T3 (da) 2000-07-06 2001-07-03 Hydropyridinderivatsyreadditionssalte
DK06017487T DK1728794T3 (da) 2000-07-06 2001-07-03 Maleatadditionssalt af hydropyridinderivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06017487T DK1728794T3 (da) 2000-07-06 2001-07-03 Maleatadditionssalt af hydropyridinderivater

Country Status (24)

Country Link
US (1) US6693115B2 (da)
EP (2) EP1728794B1 (da)
KR (6) KR20130118395A (da)
CN (1) CN1214031C (da)
AT (2) AT346071T (da)
AU (2) AU6791601A (da)
BR (1) BR0112168A (da)
CA (2) CA2415558C (da)
CY (1) CY1110395T1 (da)
CZ (1) CZ302990B6 (da)
DE (2) DE60134508D1 (da)
DK (2) DK1298132T3 (da)
ES (2) ES2276801T3 (da)
HK (2) HK1051362A1 (da)
HU (2) HU227746B1 (da)
IL (2) IL153546D0 (da)
MX (1) MXPA03000031A (da)
NO (1) NO328651B1 (da)
NZ (1) NZ523416A (da)
PL (1) PL208386B1 (da)
PT (2) PT1728794E (da)
RU (1) RU2238275C1 (da)
TW (1) TWI290927B (da)
WO (1) WO2002004461A1 (da)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002217464B2 (en) 2000-12-25 2004-12-16 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
RU2005104432A (ru) * 2002-07-18 2005-08-10 Санкио Компани, Лимитед (Jp) Лекарственная композиция для лечения артериосклероза
EP1660183A2 (en) * 2003-05-05 2006-05-31 Eli Lilly and Company Treating cardiovascular diseases with a compound of formula 1 (cs 747 - prasugrel; rn 150322-43-4)
US20060099261A1 (en) * 2004-11-08 2006-05-11 Biokey, Inc. Methods and formulations for making controlled release oral dosage form
US8586085B2 (en) * 2004-11-08 2013-11-19 Biokey, Inc. Methods and formulations for making pharmaceutical compositions containing bupropion
US20060099262A1 (en) * 2004-11-08 2006-05-11 Biokey, Inc. Methods and formulations for making controlled release oral dosage form
CN1318428C (zh) * 2005-02-23 2007-05-30 天津药物研究院 噻吩并吡啶取代的乙酰肼衍生物
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
CA2612315A1 (en) * 2005-06-17 2006-12-28 Eli Lilly And Company Dosage regimen for prasugrel
JP2009504737A (ja) * 2005-08-19 2009-02-05 イーライ リリー アンド カンパニー 脈管疾患の治療又は予防のためのpar−1/par−4阻害剤の使用
US8056072B2 (en) 2005-10-31 2011-11-08 Microsoft Corporation Rebootless display driver upgrades
SI2007362T1 (sl) 2006-04-04 2018-12-31 Kg Acquisition Llc Peroralne odmerne oblike, ki vključujejo antitrombocitno sredstvo in inhibitor kisline
TWI392681B (zh) * 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd 高純度普拉格雷及其酸加成鹽之製法
RU2461542C2 (ru) * 2006-06-27 2012-09-20 Сандоз Аг Новый способ получения соли
WO2008060934A2 (en) * 2006-11-14 2008-05-22 Acusphere, Inc. Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
TWI442947B (zh) * 2006-12-07 2014-07-01 Daiichi Sankyo Co Ltd 安定性經改善之薄膜塗覆製劑
WO2008072532A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 貯蔵安定性が改善された医薬組成物
EP2100610A4 (en) * 2006-12-07 2009-12-02 Daiichi Sankyo Co Ltd PHARMACEUTICAL COMPOSITION WITH LOW SUBSTITUTED HYDROXYPROPYL CELLULOSE
EP2100609A4 (en) * 2006-12-07 2010-01-06 Daiichi Sankyo Co Ltd MEDICAL PREPARATION IN SOLID FORM CONTAINING MANNITOL OR LACTOSE
CN101594864B (zh) * 2006-12-07 2012-04-18 第一三共株式会社 生产固体制剂的方法
SI2123656T1 (sl) * 2007-03-02 2014-09-30 Daiichi Sankyo Company, Limited Postopek izdelave hidroklorid prasugrela visoke ÄŤistosti
KR20160033792A (ko) 2007-04-27 2016-03-28 사이덱스 파마슈티칼스, 인크. 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
CZ302135B6 (cs) * 2007-07-09 2010-11-10 Zentiva, A. S. Zpusob výroby 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4, 5, 6, 7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu (prasugrelu)
WO2009062044A2 (en) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel, and its salts and polymorphs
HU230261B1 (hu) * 2007-11-27 2015-11-30 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Eljárás gyógyszeripari intermedierek elõállítására
WO2010015144A1 (zh) 2008-08-02 2010-02-11 鲁南制药集团股份有限公司 普拉格雷硫酸氢盐及其药物组合物和应用
CN101177430A (zh) * 2007-12-11 2008-05-14 鲁南制药集团股份有限公司 氢化吡啶衍生物及其盐的制备方法
WO2009098142A1 (en) * 2008-02-06 2009-08-13 Helm Ag Prasugrel salts with improved properties
WO2009129983A1 (en) * 2008-04-21 2009-10-29 Ratiopharm Gmbh Acid addition salts of prasugrel and pharmaceutical compositions comprising the same
ES2353853T3 (es) * 2008-04-25 2011-03-07 Sandoz Ag SAL HIDROGENOSULFATO DE 2-ACETOXI-5-("ALFA"-CICLOPROPILCARBONIL-2-FLUORBENCIL)-4,5,6,7-TETRAHIDROTIENO[3,2-c]PIRIDINA Y SU PREPARACIÓN.
US20090281136A1 (en) * 2008-05-08 2009-11-12 Sandeep Mhetre Prasugrel pharmaceutical formulations
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20120141468A1 (en) * 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US20130303477A1 (en) * 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US8759316B2 (en) * 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
PL2398468T3 (pl) 2009-02-17 2017-06-30 Krka, D.D., Novo Mesto Pharmaceutical compositions containing prasugrel base or pharmaceutically acceptable acid addition salts thereof and methods for their preparation
CN102365288B (zh) * 2009-03-31 2014-04-09 上海医药工业研究院 普拉格雷氢溴酸盐的晶体
EP2416799B1 (en) 2009-04-10 2017-11-01 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
KR101991367B1 (ko) 2009-05-13 2019-06-21 사이덱스 파마슈티칼스, 인크. 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
WO2011004392A1 (en) * 2009-07-06 2011-01-13 Glenmark Generics Limited Crystalline form of prasugrel hydrobromide, preparation and application thereof
DE102009036646A1 (de) 2009-08-07 2011-02-10 Ratiopharm Gmbh Prasugrel in nicht-kristalliner Form und pharmazeutische Zusammensetzung davon
CN101993447A (zh) 2009-08-26 2011-03-30 浙江华海药业股份有限公司 一种人工合成普拉格雷的方法
WO2011036533A1 (en) * 2009-09-23 2011-03-31 Glenmark Pharmaceuticals Limited Pharmaceutical composition comprising prasugrel and triflusal
PL2498731T3 (pl) 2009-11-11 2020-07-13 Chiesi Farmaceutici S.P.A. Methods of treating or preventing stent thrombosis
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
CZ2009763A3 (cs) 2009-11-16 2011-05-25 Zentiva, K. S. Zpusob výroby vysoce cistého 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráneným názvem prasugrel a jeho nových farmaceuticky prijatelných solí.
CZ2009762A3 (cs) 2009-11-16 2011-05-25 Zentiva, K. S. Nové soli 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráneným názvem prasugrel a zpusob jejich výroby
CZ2009828A3 (cs) 2009-12-09 2011-06-22 Zentiva, K.S. Zpusob prípravy hydrochloridu 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu (prasugrelu hydrochloridu) v polymorfní forme B
HU229035B1 (en) * 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel
WO2011092720A2 (en) * 2010-02-01 2011-08-04 Msn Laboratories Limited Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts
EP2360159A1 (de) 2010-02-11 2011-08-24 Ratiopharm GmbH Prasugrel in mikronisierter, kristalliner Form und pharmazeutische Zusammensetzung davon
CN102869668A (zh) 2010-03-09 2013-01-09 斯索恩有限公司 制备普拉格雷的方法
KR101184915B1 (ko) 2010-03-11 2012-09-21 한미사이언스 주식회사 고순도 프라수그렐의 제조방법
US20130053569A1 (en) 2010-03-23 2013-02-28 Jayaraman Venkat Raman Process for the preparation of prasugrel hcl salt
EP2377520A1 (de) 2010-03-24 2011-10-19 Ratiopharm GmbH Pharmazeutische Zusammensetzung des Prasugrels
CN102212068A (zh) * 2010-04-06 2011-10-12 刘桂坤 噻吩衍生物及其制备方法和在药物上的应用
SI2448945T1 (sl) 2010-04-08 2015-05-29 Teva Pharmaceutical Industries Ltd. Kristalinične oblike prasugrelovih soli
CN102212071B (zh) * 2010-04-08 2014-03-26 上海医药工业研究院 普拉格雷盐酸盐乙酸溶剂合物及其结晶和制备方法
EP2560644B1 (en) 2010-04-19 2016-06-29 Cadila Healthcare Limited A pharmaceutical composition comprising antiplatelet agents and an erythropoiesis stimulating agent
WO2012001486A1 (en) * 2010-06-28 2012-01-05 Mayuka Labs Pvt. Ltd. An improved process for the preparation of prasugrel hydrochloride and its intermediates
TR201005900A1 (tr) 2010-07-19 2012-02-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Geliştirilmiş stabiliteye sahip prasugrel granülleri.
TR201007926A1 (tr) 2010-07-19 2012-02-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Prasugrel tablet formülasyonları.
EP2409685A3 (en) 2010-07-19 2012-02-01 Sanovel Ilac Sanayi ve Ticaret A.S. Orally-disintegrating formulations of prasugrel
TR201006802A1 (tr) * 2010-08-17 2012-03-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Prasugrelin oral yolla dağılan formülasyonları.
WO2012023145A2 (en) * 2010-08-18 2012-02-23 Hetero Research Foundation Prasugrel hydrochloride crystalline particles
HU1000565A2 (en) 2010-10-22 2012-05-02 Egis Gyogyszergyar Nyrt Process for the preparation of pharmaceutically active compound and intermediers
CN101985450B (zh) * 2010-11-02 2012-07-11 北京赛科药业有限责任公司 普拉格雷盐及其制备方法
CN102532157A (zh) * 2010-12-16 2012-07-04 瑞阳制药有限公司 普拉格雷的可药用酸加成盐化合物及其制备方法
CZ305314B6 (cs) * 2010-12-30 2015-07-29 Zentiva, K.S. Nový hydrobromid formy C 5-[2-cyklopropyl-1-(2-fluorofenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráněným názvem prasugrel a způsob jeho výroby
CN102199163A (zh) * 2011-04-01 2011-09-28 中国药科大学 2-羟基四氢噻吩并吡啶衍生物及其制备方法与在制药中的用途
CN102746318A (zh) * 2011-04-20 2012-10-24 上海信谊药厂有限公司 用于制备普拉格雷盐酸盐的方法
EP2709446A2 (en) 2011-05-17 2014-03-26 Velico Medical, Inc. Platelet storage using a sialidase inhibitor
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
CN102838618A (zh) * 2011-06-22 2012-12-26 广东东阳光药业有限公司 一种制备普拉格雷的方法及普拉格雷盐酸盐新晶型
JP2014524929A (ja) 2011-07-28 2014-09-25 ラボラトリオス レスヴィ,エス.エル. プラスグレルの調製方法
CN103102355A (zh) * 2011-11-09 2013-05-15 丁克 具有旋光性的四氢噻吩并吡啶化合物
CZ2011872A3 (cs) 2011-12-22 2013-07-03 Zentiva, K.S. Farmaceutická formulace prasugrelu hydrobromidu
US8603537B2 (en) 2012-04-02 2013-12-10 Egis Pharmaceuticals Plc Prasugrel containing quickly released stable oral pharmaceutical compositions
EP2903430A1 (en) 2012-10-05 2015-08-12 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
EP2722036A1 (en) 2012-10-19 2014-04-23 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral formulations of prasugrel
WO2014060554A1 (en) 2012-10-19 2014-04-24 Sanovel Ilac Sanayi Ve Ticaret A.S. Prasugrel formulations
PL402028A1 (xx) 2012-12-12 2014-06-23 Instytut Farmaceutyczny A method of producing pharmaceutical purity polymorph B form of Prasugrel hydrochloride
HU230649B1 (en) 2013-01-24 2017-05-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Improved process for producing pharmaceutical agent prasugrel and 2-(2-fluorophenyl)-1-cyclopropylethanone intermediate
WO2014120886A1 (en) 2013-01-30 2014-08-07 Velico Medical, Inc. Platelet additive solution having a self-assembling hydrogel-forming peptide
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
EP2979693A1 (en) 2014-08-01 2016-02-03 Zaklady Farmaceutyczne Polpharma SA Pharmaceutical composition comprising prasugrel or pharmaceutically acceptable salt thereof and process for its preparation
CN104479502A (zh) * 2014-12-31 2015-04-01 江阴市天邦涂料股份有限公司 一种水性防腐涂料
WO2016122421A1 (en) 2015-01-29 2016-08-04 Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. Stable pharmaceutical compositions containing prasugrel base
WO2016203018A1 (en) 2015-06-19 2016-12-22 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical compositions of prasugrel hydrobromide
EP3156049A1 (en) 2015-10-15 2017-04-19 Alembic Pharmaceuticals Limited Pharmaceutical composition of prasugrel
EP3158993A1 (en) 2015-10-22 2017-04-26 Zaklady Farmaceutyczne Polpharma SA Process for preparing a tablet comprising prasugrel or pharmaceutically acceptable salt thereof
HU231079B1 (hu) 2016-06-23 2020-06-29 Richter Gedeon Nyrt. Process for the preparation of high purity Prasugrel by removal of bromopentyl impurities
WO2018073437A1 (en) 2016-10-21 2018-04-26 Laboratorios Lesvi, Sl Pharmaceutical formulations of prasugrel and processes for the preparation thereof
CN106632391A (zh) * 2016-12-23 2017-05-10 山东鲁抗医药股份有限公司 一种盐酸普拉格雷化合物及其制备方法和含有盐酸普拉格雷的药物组合物
KR102063862B1 (ko) 2018-08-09 2020-01-08 한국기술교육대학교 산학협력단 Qr코드 기반의 공유시점관리 시스템

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141894A (en) * 1976-11-02 1979-02-27 Eli Lilly And Company Trans-5a-aryl-decahydrobenzazepines
FR2576901B1 (fr) 1985-01-31 1987-03-20 Sanofi Sa Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique
JP2506376B2 (ja) * 1987-07-16 1996-06-12 三菱化学株式会社 2−(4−メチルアミノブトキシ)ジフェニルメタン・塩酸塩の製造方法
FI101150B (fi) 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
US5342851A (en) * 1992-10-07 1994-08-30 Mcneil-Ppc, Inc. Substituted thiazole derivatives useful as platelet aggregation inhibitors
JPH07188168A (ja) * 1993-12-28 1995-07-25 Daicel Chem Ind Ltd ジヒドロピリジン化合物およびその製造方法
AU2002217464B2 (en) * 2000-12-25 2004-12-16 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
CZ2009762A3 (cs) 2009-11-16 2011-05-25 Zentiva, K. S. Nové soli 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráneným názvem prasugrel a zpusob jejich výroby
CZ305314B6 (cs) 2010-12-30 2015-07-29 Zentiva, K.S. Nový hydrobromid formy C 5-[2-cyklopropyl-1-(2-fluorofenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráněným názvem prasugrel a způsob jeho výroby

Also Published As

Publication number Publication date
HU0301645A2 (hu) 2003-09-29
EP1728794A1 (en) 2006-12-06
CA2703697C (en) 2012-09-04
HU230762B1 (en) 2018-03-28
PT1298132E (pt) 2007-01-31
MXPA03000031A (es) 2003-10-15
WO2002004461A1 (fr) 2002-01-17
CN1214031C (zh) 2005-08-10
DE60124712D1 (de) 2007-01-04
KR20120062906A (ko) 2012-06-14
AT398624T (de) 2008-07-15
CY1110395T1 (xx) 2015-04-29
PL208386B1 (pl) 2011-04-29
ES2308633T3 (es) 2008-12-01
DK1728794T3 (da) 2008-09-22
EP1298132B1 (en) 2006-11-22
KR20100105763A (ko) 2010-09-29
CZ200318A3 (cs) 2003-05-14
NZ523416A (en) 2004-10-29
RU2238275C1 (ru) 2004-10-20
IL153546D0 (en) 2003-07-06
KR20080021152A (ko) 2008-03-06
EP1298132A1 (en) 2003-04-02
AT346071T (de) 2006-12-15
US20030134872A1 (en) 2003-07-17
AU2001267916B2 (en) 2004-09-09
DE60134508D1 (de) 2008-07-31
KR20090033917A (ko) 2009-04-06
TWI290927B (en) 2007-12-11
EP1728794B1 (en) 2008-06-18
ES2276801T3 (es) 2007-07-01
KR20030014294A (ko) 2003-02-15
BR0112168A (pt) 2003-09-02
CA2415558C (en) 2010-09-14
CA2703697A1 (en) 2002-01-17
PT1728794E (pt) 2008-07-15
CZ302990B6 (cs) 2012-02-08
KR20130118395A (ko) 2013-10-29
CN1452624A (zh) 2003-10-29
US6693115B2 (en) 2004-02-17
HU1100350A2 (en) 2003-09-29
DE60124712T2 (de) 2007-09-13
HU227746B1 (en) 2012-02-28
IL153546A (en) 2007-03-08
EP1298132A4 (en) 2004-03-10
HU0301645A3 (en) 2006-05-29
NO20030022D0 (no) 2003-01-03
AU6791601A (en) 2002-01-21
HK1096684A1 (en) 2007-07-20
NO328651B1 (no) 2010-04-19
PL359393A1 (xx) 2004-08-23
NO20030022L (no) 2003-03-05
CA2415558A1 (en) 2002-01-17
HK1051362A1 (en) 2003-08-01

Similar Documents

Publication Publication Date Title
DE60126142D1 (de) Bioabsorbierbare wundauflage
DK1296587T3 (da) Analytovervåger
DE60112603D1 (de) Perkutane aortenklappe
DK1208782T3 (da) Perkolationsindretning
DE60111771D1 (de) Mikroklingeanordungsaufprallapplikator
DK1683491T3 (da) Anastomoseforbindelsesapplikator
DK1294715T3 (da) Quinazolinditosylatsaltforbindelser
DE60116715D1 (de) Ablationskartierungskatheter
DK1335679T3 (da) Tandbörstningssystem
DK1310136T3 (da) Bredbåndsminiaturetransducer
DK1356188T3 (da) Fluidblandingssystem
DK1439306T3 (da) Bölgeenergiomformer
DK1158185T3 (da) Hurtigfastgörelseselement
DK1298132T3 (da) Hydropyridinderivatsyreadditionssalte
DK1330611T3 (da) Teleskoparm
DE60024877D1 (de) Elektrokauterisationskatheter
DE60133377D1 (de) Dezellularisierte gefässprothesen
DE60132227D1 (de) Tintenstrahlaufzeichungsmaterial
DE60113289D1 (de) Schergelzusammensetzungen
DK1296647T3 (da) Polymermicellepræparater
DK1345959T3 (da) Membranscaffoldproteiner
DK2312115T3 (da) Rørindbygningsværktøj
DK1404939T3 (da) Dørskinnesystem
DK1265560T3 (da) Patellalejeimplantat
DK1328919T3 (da) Pegeværktöj